Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

USP9X deubiquitinates CTNNB1. 5 / 5

1 | 1 3

➶

reach

"As shown in Figure XREF_FIG, knockdown of USP9X increased the ubiquitination of beta-catenin and subsequent degradation."

27783990

➶

reach

"Deubiquitinase USP9X deubiquitinates beta-catenin and promotes high grade glioma cell growth."

27783990

➶

trips

"Deubiquitinase USP9X deubiquitinates β-catenin and promotes high grade glioma cell growth."

27783990

➶

reach

"In the Wnt pathway, FAM deubiquitinates betacatenin, preventing its degradation in mammalian cells, but the effect of FAM activity on Wnt signaling was not noted."

18797952

➶

ubibrowser

"Additionally, DUBs USP14, USP15, USP47, and Fam/USP9X have been reported to prevent β-catenin turnover by inhibiting its Ub-proteasomal degradation"

29080116

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...

Other Services

This Service

This Project

IndraLab

Statements

USP9X deubiquitinates CTNNB1. 5 / 5

Our Sources:

Databases

Reading